Wide Benefit, Less Toxic
24/01/2023
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin
Overview PPHI Website
07/10/2022
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali
Virtual Liver Update 2022 – Clinical Associate Prof Tai Wai Meng David, Singapore Session
26/09/2022
< 1 mn readClinical Associate Prof Tai Wai Meng David was giving his presentation on Implications of Immunotherapy Data in Unresectable HCC. There were three highlights from his session:
Indonesian consensus on systemic therapies for hepato cellular carcinoma
20/09/2022
< 1 mn readAbstract Hepatocellular carcinoma (HCC) is a deadly cancer with a rising incidence in the last 20 years. Most patients are diagnosed late when curative treatment
Jangan Takut Dulu, Begini Cara Penyakit Hepatitis Bisa Menular
06/02/2020
2 mn readJakarta – Hepatitis berasal dari kata hepar (hati) dan titis (radang). Penyakit radang hati ini tidak hanya disebabkan oleh virus
GUIDELINES
06/02/2020
< 1 mn readKonsensus Hepatitis C 2003 (Ringkasan) Konsensus PPHI tentang Hepatitis C Konsensus ini berisi tentang penatalaksanaan Hepatitis C kronik, yang membahas mulai dari riwayat alamiah virus
Video Animasi Hepatitis C PPHI
06/02/2020
< 1 mn readPerhimpunan Peneliti Hati Indonesia (PPHI) meluncurkan video animasi pertama berisi informasi tentang penyakit Hepatitis C
PEPERANGAN DUNIA MELAWAN KANKER
06/02/2020
3 mn readThe International Agency for Research on Cancer (IARC), perkumpulan spesialis kanker World Health Organization (WHO), baru-baru ini meluncurkan laporan kanker dunia 2014,
Wajib tau !! Ini Penjelasan Tentang Hepatitis A
08/01/2020
2 mn readHepatitis A merupakan penyakit menular yang disebabkan oleh virus hepatitis A. Infeksi virus hepatitis A mengakibatkan peradangan pada hati. Virus hepatitis A ditularkan melalui makanan
Artikel Populer:
Wide Benefit, Less Toxic
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin
Overview PPHI Website
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali
Enhancing Interprofessional Collaboration for Improving Hepatobiliary Diseases Management
2 mn read“Virtual The 14th Liver Update and The Annual Scientific Meeting of Ina ASL/PPHI 2022” symposium is organized by Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital and Indonesian Association for the Study of the Liver (Ina ASL/PPHI).
Virtual Liver Update 2022 – Clinical Associate Prof Tai Wai Meng David, Singapore Session
< 1 mn readClinical Associate Prof Tai Wai Meng David was giving his presentation on Implications of Immunotherapy Data in Unresectable HCC. There were three highlights from his session:
Indonesian consensus on systemic therapies for hepato cellular carcinoma
< 1 mn readAbstract Hepatocellular carcinoma (HCC) is a deadly cancer with a rising incidence in the last 20 years. Most patients are diagnosed late when curative treatment